← Product Code [DRX](/submissions/CV/subpart-c%E2%80%94cardiovascular-monitoring-devices/DRX) · K071576 # TEXTRONICS ECG ELECTRODE (K071576) _Textronics, Inc. · DRX · Nov 2, 2007 · Cardiovascular · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/CV/subpart-c%E2%80%94cardiovascular-monitoring-devices/DRX/K071576 ## Device Facts - **Applicant:** Textronics, Inc. - **Product Code:** [DRX](/submissions/CV/subpart-c%E2%80%94cardiovascular-monitoring-devices/DRX.md) - **Decision Date:** Nov 2, 2007 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 870.2360 - **Device Class:** Class 2 - **Review Panel:** Cardiovascular ## Indications for Use The Textronics™ ECG Electrode is intended for use in general electrocardiograph monitoring and recording procedures. The Textronics™ ECG Electrode is indicated for use with most ECG instruments on the market. It is indicated for applications including resting ECGs, exercise ECGs, and/or ambulatory monitoring. The device is indicated for both prescription and over-the-counter use. ## Device Story Textronics ECG Electrode consists of textile-based electrodes integrated into fabric garments (chest straps, wrist bands, shirts, bras, vests). Electrodes utilize silver-coated polyamide yarns knitted with non-conductive yarns (cotton, spandex, polyester, nylon). Device connects to standard ECG instruments via conductive snap. Used in clinical or home settings for resting, exercise, or ambulatory ECG monitoring. Provides electrical signal acquisition for ECG recording; healthcare providers or patients use output to monitor cardiac activity. Benefits include comfortable, wearable form factor for continuous or intermittent cardiac monitoring. ## Clinical Evidence Bench testing only. Laboratory comparison of ECG tracings between subject device and commercially available electrodes using simultaneous recording. Results demonstrated equivalent clarity and resolution of tracings. ## Technological Characteristics Textile-based electrodes; conductive silver-coated polyamide yarns; non-conductive yarns (cotton, spandex, polyester, nylon). Fabric housing (polypropylene, nylon, Lycra Spandex, polyester, cotton). Form factors: chest straps, wrist bands, shirts, bras, vests. Connection: conductive snap. Passive sensing. ## Regulatory Identification An electrocardiograph electrode is the electrical conductor which is applied to the surface of the body to transmit the electrical signal at the body surface to a processor that produces an electrocardiogram or vectorcardiogram. ## Special Controls *Classification.* Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 870.9. The special control for this device is the FDA guidance document entitled “Class II Special Controls Guidance Document: Electrocardiograph Electrodes.” See § 870.1(e) for availability information of guidance documents. ## Predicate Devices - Unomedical 4560M Unilect Short Term ECG Electrodes ([K944497](/device/K944497.md)) - Medi-Trace model 530 ECG Conductive Adhesive Electrodes ([K945479](/device/K945479.md)) - Accuheart™ Electrode belt ([K043361](/device/K043361.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ K071576 # 510(k) SUMMARY # Textronics, Inc.'s ECG Electrode NOV - 2 2007 # Submitter's Name, Address, Telephone Number, Contact Person, and Date Prepared Textronics, Inc. 3825 Lancaster Pike Wilmington DE 19805 Phone: (302) 351-2162 Facsimile: (302) 998-7870 Contact Person: Michael McBrearty, Ph.D. Date Prepared: May 31, 2007 ### Name of Device Textronics ™ ECG Electrode #### Common or Usual Name ECG Electrode ## Classification Name Electrode, Electrocardiograph Page 1 of 3 {1}------------------------------------------------ ### Predicate Devices Unomedical 4560M Unilect Short Term ECG Electrodes (K944497) Medi-Trace model 530 ECG Conductive Adhesive Electrodes (K945479) Accuheart™ Electrode belt (K043361) ## Intended Use / Indications for Use The Textronics™ ECG Electrode is intended for use in general electrocardiograph monitoring and recording procedures. The Textronics™ ECG Electrode is indicated for use with most ECG instruments on the market. It is indicated for applications including resting ECGs, exercise ECGs, and/or ambulatory monitoring. The device is indicated for both prescription and over-the-counter use. ### Technological Characteristics The Textronics ™ ECG Electrode consists of electrodes, an exterior housing for the electrodes that makes contact with the patient, and a means of connecting the device to an ECG instrument. The Textronics™ ECG Electrode has textilebased electrodes made of electrically conductive yarns knitted together with electrically non-conductive yarns. The conductive yarns are silver coated polyamide (nylon). The non-conductive yarns can include cotton, spandex, polyester, and/or nylon. The Textronics™ ECG Electrode's textile-based electrodes have an exterior housing made of fabric, which can be made out of common textile materials, including polypropylene, nylon, Lycra® Spandex, polyester, and/or cotton. This fabric exterior housing can take the shape of a variety of garments, such as chest straps, wrist bands, shirts, bras, or vests. The Textronics™ ECG Electrode connects to ECG instruments via a conductive snap. Page 2 of 3 {2}------------------------------------------------ ### Performance Data The Textronics™ ECG Electrode has been tested in the lab using ECG recording devices with the commercially available ECG electrodes and the Textronics ™ ECG Electrode used simultaneously. ECGs were recorded, and the tracings were compared. In all instances, the Textronics™ ECG Electrode functioned as intended and the clarity and resolution of the tracings were observed to be substantially equivalent to the commercially available electrodes. #### Substantial Equivalence The Textronics™ ECG Electrode is substantially equivalent to several predicates, including the Unomedical 4560M Unilect Electrodes, the Medi-Trace model 530 ECG Conductive Electrodes and the Accuheart™ Electrode belt. The Textronics™ ECG Electrode has the same intended uses and similar indications, technological characteristics, and principles of operation as its predicate devices. The minor technological differences between the Textronics™ ECG Electrode and its predicate devices raise no new issues of safety or effectiveness. Performance data demonstrate that the Textronics™ ECG Electrode performs very similarly to commercially available ECG electrodes. Thus, the Textronics™ ECG Electrode is substantially equivalent. {3}------------------------------------------------ Public Health Service Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 NOV - 2 2007 Textronics Inc. c/o Ms. Janice Hogan, Esq. Hogan & Hartson, LLP 1835 Market Street, 28th Floor Philadelphia, PA 19103 Re: K071576 Textronics™ ECG Electrode Regulation Number: 21 CFR 870.2360 Regulation Name: Electrocardiograph Electrode Regulatory Class: Class II (two) Product Code: DRX Dated: October 242007 Received: October 24, 2007 Dear Ms. Hogan: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. Iisting of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {4}------------------------------------------------ Page 2 - Ms. Janice Hogan, Esq. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html. Sincerely yours, B/yummumana for Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {5}------------------------------------------------ #### Indications for Use Statement K071576 510(k) Number (if known): Device Name: Textronics™ ECG Electrode Indications for Use: The Textronics ™ ECG Electrode is intended for use in general electrocardiograph monitoring and recording procedures. The Textronics™ ECG Electrode is indicated for use with most ECG instruments on the market. It is indicated applications including resting ECGs, exercise ECGs, and/or ambulatory monitoring. Prescription Use X (Part 21 C.F.R. 801 Subpart D) AND/OR Over-The-Counter X (21 C.F.R. 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE -- CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Bhimmer ) vis Sign-Off ivision of Cardiovase >10(k) Nu of Page --- **Source:** [https://fda.innolitics.com/submissions/CV/subpart-c%E2%80%94cardiovascular-monitoring-devices/DRX/K071576](https://fda.innolitics.com/submissions/CV/subpart-c%E2%80%94cardiovascular-monitoring-devices/DRX/K071576) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com